Changes in the PD-1 and PD-L1 expressions of splenic dendritic cells in multiple-organ dysfunction syndrome mice and their significance

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 7666-7672

  Liu, Q ^a   Lu, J Y ^a   Wang, X H ^a   Qu, B J ^a   Li, S R ^a   Kang, J R ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Dendritic cells; Multiple organ failure; PD 1 PD L1; Spleen

Indexed keywords

CD11 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; HLA A ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; CD274 PROTEIN, MOUSE; PDCD1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PERITONEAL CAVITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYEMIA; SEPSIS; SEPTICEMIA; SIGNAL TRANSDUCTION; SPLEEN CELL; ANIMAL; C57BL MOUSE; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPLEEN;

MUS;

ANIMALS; ANTIGENS, CD274; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNOPHENOTYPING; MALE; MICE; MICE, INBRED C57BL; MULTIPLE ORGAN FAILURE; PROGRAMMED CELL DEATH 1 RECEPTOR; SPLEEN;

EID: 84907821987     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.September.26.4     Document Type: Article

References (20)

1. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, et al. (2012). Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366: 2455-2465.
2. del Rio ML, Buhler L, Gibbons C, Tian J, et al. (2008). PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl. Int. 21: 1015-1028.
3. Dong H and Chen X (2006). Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol. Immunol. 3: 179-187.
4. Freeman GJ, Long AJ, Iwai Y, Bourque K, et al. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
5. Greenwald RJ, Freeman GJ and Sharpe AH (2005). The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
6. Keir ME, Francisco LM and Sharpe AH (2007). PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19: 309-314.
7. Keir ME, Butte MJ, Freeman GJ and Sharpe AH (2008). PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
8. Li ZH, Lu JY, Wang XH and Yang Y (2003). Change in IL-12 expression and its role in immunodissonance in mods mice. Med. J. Chin. People’s Liberation Army 28: 887.
9. Lu JY, Li ZH, Wang XH and Yang Y (2007). Pathologic alteration of spleen and its dendritic cells in patients with multiple organ dysfunction syndrome: An observation of 52 autopsied cases. Chin. J. Diagnostic. Pathol. 14: 172-175.
10. Lu JY, Li ZH, Wang XH, Yang Y, et al. (2006). Changes in spleen dendritic cells in multiple organ dysfunction syndrome in mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18: 24-27.
11. Lyn-Kew K and Standiford TJ (2008). Immunosuppression in sepsis. Curr. Pharm. Des. 14: 1870-1881.
12. Nishimura H and Honjo T (2001). PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22: 265-268.
13. Okazaki T and Honjo T (2007). PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19: 813-824.
14. Parekh VV, Lalani S, Kim S, Halder R, et al. (2009). PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. J. Immunol. 182: 2816-2826.
15. Peng G, Luo B, Li J, Zhao D, et al. (2011). Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients. J. Clin. Immunol. 31: 195-204.
16. Poehlmann H, Schefold JC, Zuckermann-Becker H, Volk HD, et al. (2009). Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit. Care 13: R119.
17. Riley JL (2009). PD-1 signaling in primary T cells. Immunol. Rev. 229: 114-125.
18. Selenko-Gebauer N, Majdic O, Szekeres A, Höfler G, et al. (2003). B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170: 3637-3644.
19. Tseng SY, Otsuji M, Gorski K, Huang X, et al. (2001). B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193: 839-846.
20. Xu H, Wang X, Pahar B, Moroney-Rasmussen T, et al. (2010). Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression. J. Immunol. 185: 7340-7348.